Cargando…

Effect of intravitreal ranibizumab on the ocular circulation of the untreated fellow eye

PURPOSE: To evaluate the effects of unilateral intravitreal ranibizumab (IVR) on the ocular circulation of the fellow eyes. METHODS: Fifteen eyes of 15 patients with macular edema (average age 69.6 ± 11.8 years) were studied. Eleven eyes had diabetic macular edema (DME) and four eyes had macular ede...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugimoto, Masahiko, Nunome, Takayasu, Sakamoto, Rie, Kobayashi, Maki, Kondo, Mineo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Retinal Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541094/ https://www.ncbi.nlm.nih.gov/pubmed/28656342 http://dx.doi.org/10.1007/s00417-017-3692-z

Ejemplares similares

Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes
por: Sugimoto, Masahiko, et al.
Publicado: (2022)

Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort
por: Liu, Siyin, et al.
Publicado: (2022)

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
por: Blazaki, Styliani, et al.
Publicado: (2023)

Impact on visual acuity and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (MERCURY)
por: Sakamoto, Taiji, et al.
Publicado: (2021)

Intravitreal dexamethasone: variation of surgical technique and prevention of ocular complications with ASOCT follow-up
por: Nuzzi, Raffaele, et al.
Publicado: (2022)

Effects of suspension of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration in clinical setting
por: Matsubara, Hisashi, et al.
Publicado: (2022)

Disease-modifying effects of ranibizumab for central retinal vein occlusion
por: Huang, Jason M., et al.
Publicado: (2021)

Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema
por: Wong, Yun, et al.
Publicado: (2016)

Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration
por: Marquis, Liza-Marie, et al.
Publicado: (2020)

Rhegmatogenous retinal detachment following intravitreal ocriplasmin
por: Madi, Haifa A., et al.
Publicado: (2016)

Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment
por: Karst, Sonja G., et al.
Publicado: (2017)

Posterior vitreous detachment following intravitreal drug injection
por: Geck, Ulrich, et al.
Publicado: (2013)

FUSION regimen: ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and relatively good baseline visual acuity
por: Monés, Jordi, et al.
Publicado: (2012)

Treatment contentment and preference of patients undergoing intravitreal anti-VEGF therapy
por: Kellner, Ulrich, et al.
Publicado: (2021)

Intravitreal injection associated rhegmatogenous retinal detachment: outcomes of a European analysis
por: Vounotrypidis, Efstathios, et al.
Publicado: (2021)

Impact of intravitreal injection therapy on contrast sensitivity in patients with nAMD and DME
por: Dieke, Sebastian, et al.
Publicado: (2023)

Legal obligation in the general population: face mask influence on endophthalmitis after intravitreal injection
por: Neubauer, Jonas, et al.
Publicado: (2022)

Long-term outcomes of intravitreal therapy for symptomatic diabetic macular oedema in a real-world setting in Switzerland
por: Zirpel, Johanna J., et al.
Publicado: (2021)

Effects of delay in anti-vascular endothelial growth factor intravitreal injections for neovascular age-related macular degeneration
por: Hanhart, Joel, et al.
Publicado: (2022)

Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion
por: Jaissle, Gesine B., et al.
Publicado: (2010)

Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial
por: Eter, Nicole, et al.
Publicado: (2016)

Long-term outcomes of intravitreal activated protein C injection for ischemic central retinal vein occlusion: an extension trial
por: Hara, Chikako, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic’s first wave on the care and treatment situation of intravitreal injections in a German metropolitan region
por: Stemplewitz, Birthe, et al.
Publicado: (2022)

Ciliary body length revisited by anterior segment optical coherence tomography: implications for safe access to the pars plana for intravitreal injections
por: Lincke, Joel-Benjamin, et al.
Publicado: (2020)

The detrimental effects of delayed intravitreal anti-VEGF therapy for treating retinal pathology: lessons from a forced test-case
por: Navarrete, Ana, et al.
Publicado: (2022)

Impact of COVID-19 on outpatient visits and intravitreal treatments in a referral retina unit: let’s be ready for a plausible “rebound effect”
por: Borrelli, Enrico, et al.
Publicado: (2020)

Two year result of intravitreal bevacizumab for diabetic macular edema using treat and extend protocol
por: Sugimoto, Masahiko, et al.
Publicado: (2017)

Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France
por: Korobelnik, Jean-François, et al.
Publicado: (2016)

Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study
por: Li, Xiaoxin, et al.
Publicado: (2017)

Final 4-year results of the RAINBOW real-world study: intravitreal aflibercept dosing regimens in France in treatment-naïve patients with neovascular age-related macular degeneration
por: Cohen, Salomon-Yves, et al.
Publicado: (2022)

Prospective PED-study of intravitreal aflibercept for refractory vascularized pigment epithelium detachment due to age-related macular degeneration: morphologic characteristics of non-responders in optical coherence tomography
por: Clemens, C. R., et al.
Publicado: (2020)

Importance of continuous treatment with intravitreal aflibercept injections in patients with neovascular age-related macular degeneration—12-month post hoc analysis of the PERSEUS real-world evidence study
por: Wachtlin, Joachim, et al.
Publicado: (2020)

PERSEUS-IT 24-month analysis: a prospective observational study to assess the effectiveness of intravitreal aflibercept in routine clinical practice in Italy in patients with neovascular age-related macular degeneration
por: Nicolò, Massimo, et al.
Publicado: (2022)

PERSEUS 24-month analysis: a prospective non-interventional study to assess the effectiveness of intravitreal aflibercept in routine clinical practice in Germany in patients with neovascular age-related macular degeneration
por: Eter, Nicole, et al.
Publicado: (2021)

Posterior staphyloma is associated with the microvasculature and microstructure of myopic eyes
por: Nie, Fen, et al.
Publicado: (2021)

Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study
por: Ohji, Masahito, et al.
Publicado: (2021)

Investigation of precursor lesions of polypoidal choroidal vasculopathy using contralateral eye findings
por: Kang, Se Woong, et al.
Publicado: (2016)

Impact of peripapillary staphylomas on the vascular and structural characteristics in myopic eyes: a propensity score matching analysis
por: Nie, Fen, et al.
Publicado: (2023)

Pattern recognition can detect subtle field defects in eyes of HIV individuals without retinitis under HAART
por: Goldbaum, Michael H., et al.
Publicado: (2010)

Inverted internal limiting membrane flap technique in eyes with large idiopathic full-thickness macular hole: long-term functional and morphological outcomes
por: Bleidißel, Nathalie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_av7v8r2l6s1cvhdb18b2m7c18k